Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patients

Chow, R., Chiu, L., Herrstedt, J., Aapro, M., Lock, M., DeAngelis, C., & Navari, R. M. (2021). Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patients. Supportive Care in Cancer, 29(8), 4269–4275. https://doi.org/10.1007/s00520-020-05977-x
Authors:
Ronald Chow
Leonard Chiu
Jørn Herrstedt
Matti Aapro
Michael Lock
Carlo DeAngelis
Rudolph M. Navari
Affiliated Authors:
Leonard Chiu
Columbia Affiliation:
Author Keywords:
chemotherapy-induced nausea and vomiting
cost-effectiveness analysis
highly emetogenic chemotherapy
olanzapine
elink
Publication Type:
Article
Unique ID:
10.1007/s00520-020-05977-x
PMID:
33409724
DOI:
10.1007/s00520-020-05977-x
Journal:
Supportive Care in Cancer
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: